Processing of C5a by human polymorphonuclear leukocytes. 1998

G Hetland, and P H Pfeifer, and T E Hugli
Department of Immunology, The Scripps Research Institute, La Jolla, California 92037, USA.

Uptake of human C5a by neutrophils was monitored in vitro using both 125I-labeled and unlabeled C5a. The ligand was internalized by the cells in a dose-dependent manner and maximal binding/uptake was observed after 5 min of incubation. Neutrophils were incubated with labeled C5a and the cytosol and supernatant were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and autoradiography. C5a degradation products were primarily observed in the supernatant, whereas most of the protein remained intact in the cytosol even after 60 min of incubation. Cytosol from neutrophils incubated for 20 min with unlabeled C5a was examined by radioimmunoassay and found to contain antigenically intact C5a and retained the ability to induce a neutrophil (shape change) response. The functional activity of C5a recovered from the cytosol was inhibited by antibodies to either C5a or the C5a receptor (CD88). This data supports our hypothesis that although C5a is internalized it remains antigenically intact and functionally active inside the cell and is primarily degraded extracellularly.

UI MeSH Term Description Entries
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D004306 Dose-Response Relationship, Immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. Immunologic Dose-Response Relationship,Relationship, Immunologic Dose-Response,Dose Response Relationship, Immunologic,Dose-Response Relationships, Immunologic,Immunologic Dose Response Relationship,Immunologic Dose-Response Relationships,Relationship, Immunologic Dose Response,Relationships, Immunologic Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015936 Complement C5a The minor fragment formed when C5 convertase cleaves C5 into C5a and COMPLEMENT C5B. C5a is a 74-amino-acid glycopeptide with a carboxy-terminal ARGININE that is crucial for its spasmogenic activity. Of all the complement-derived anaphylatoxins, C5a is the most potent in mediating immediate hypersensitivity (HYPERSENSITIVITY, IMMEDIATE), smooth MUSCLE CONTRACTION; HISTAMINE RELEASE; and migration of LEUKOCYTES to site of INFLAMMATION. C5a Complement,Complement 5a,Complement Component 5a,C5a, Complement,Complement, C5a,Component 5a, Complement
D018375 Neutrophil Activation The process in which the neutrophil is stimulated by diverse substances, resulting in degranulation and/or generation of reactive oxygen products, and culminating in the destruction of invading pathogens. The stimulatory substances, including opsonized particles, immune complexes, and chemotactic factors, bind to specific cell-surface receptors on the neutrophil. Activation, Neutrophil,Activations, Neutrophil,Neutrophil Activations

Related Publications

G Hetland, and P H Pfeifer, and T E Hugli
January 1988, The Journal of biological chemistry,
G Hetland, and P H Pfeifer, and T E Hugli
August 1978, Proceedings of the National Academy of Sciences of the United States of America,
G Hetland, and P H Pfeifer, and T E Hugli
September 1985, Journal of immunology (Baltimore, Md. : 1950),
G Hetland, and P H Pfeifer, and T E Hugli
January 1991, Complement and inflammation,
G Hetland, and P H Pfeifer, and T E Hugli
November 1979, Proceedings of the National Academy of Sciences of the United States of America,
G Hetland, and P H Pfeifer, and T E Hugli
January 1993, Journal of immunology (Baltimore, Md. : 1950),
G Hetland, and P H Pfeifer, and T E Hugli
February 1990, Journal of immunology (Baltimore, Md. : 1950),
G Hetland, and P H Pfeifer, and T E Hugli
September 1977, Bollettino dell'Istituto sieroterapico milanese,
G Hetland, and P H Pfeifer, and T E Hugli
February 1991, Proceedings of the National Academy of Sciences of the United States of America,
G Hetland, and P H Pfeifer, and T E Hugli
May 1980, The Journal of clinical investigation,
Copied contents to your clipboard!